Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy ; volume:55 ; number:3 ; day:14 ; month:9 ; year:2015 ; pages:381-396 ; date:3.2016
Clinical pharmacokinetics ; 55, Heft 3 (14.9.2015), 381-396, 3.2016
- Creator
-
Colbers, Angela
- Contributor
-
Greupink, Rick
Litjens, Carlijn
Burger, David
Russel, Frans G. M.
SpringerLink (Online service)
- DOI
-
10.1007/s40262-015-0325-8
- URN
-
urn:nbn:de:1111-2016022233764
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Colbers, Angela
- Greupink, Rick
- Litjens, Carlijn
- Burger, David
- Russel, Frans G. M.
- SpringerLink (Online service)
Other Objects (12)
Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
Influence of ritonavir on the pharmacokinetics and pharmacodynamics of loperamide
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir
In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Safety and efficacy of lopinavir/ritonavir compared to nelfinavir-based HAART during pregnancy
Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
Influence of ritonavir on the pharmacokinetics and pharmacodynamics of loperamide
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir
In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life
Safety and efficacy of lopinavir/ritonavir compared to nelfinavir-based HAART during pregnancy
Physiologically Based Modelling Framework for Prediction of Pulmonary Pharmacokinetics of Antimicrobial Target Site Concentrations
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals
Influence of ritonavir on the pharmacokinetics and pharmacodynamics of loperamide
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir
In silico molecular targets, docking, dynamics simulation and physiologically based pharmacokinetics modeling of oritavancin
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
Guiding dose adjustment of amlodipine after co-administration with ritonavir containing regimens using a physiologically-based pharmacokinetic/pharmacodynamic model
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life